Mutations or dysregulation of ARRDC3 can affect these pathways and have been linked to various disorders, including obesity, cancer, and metabolic syndromes (Batista et al., 2020; Wedegaertner et al., 2022). This evidence concerns the gene ARRDC3 and obesity disorder.